• ROW-Products
    • US-Products
Novus Scientific ROW
  • Home
  • TIGR Matrix
    • Product information
    • Patient Information
    • Manufacturing
  • Evidence
    • AWR
      • Published
      • Posters
      • Cases
      • Procedure tips and tricks
      • Brochure
    • Breast Reconstruction
      • Published
      • Brochure
  • Events & News
  • Company Information
    • Contact Us
    • Sales Channels
    • Job Openings
    • About Us
Select Page

Novus Scientific invited to discuss innovations in Breast Surgery at the Medical Faculty in Paris

by editor | Apr 7, 2021 | Breast, Event

Topics How to renew and guarantee maximum safety for patients with breast cancer – an industry point of view TIGR® Matrix Surgical Mesh, Novus Scientific AB, Sweden Pre-clinical study Clinical evaluation Studies Safety and performance Clinical studies...

Recent posts

  • Comparing Complications of Biologic and Synthetic Mesh in Breast Reconstruction: A Systematic Review and Network Meta-Analysis 6 February, 2023
  • Are patients most satisfied with a synthetic or a biological mesh in dual-plane immediate breast reconstruction after 5 years? A randomized controlled trial comparing the two meshes in the same patient 18 November, 2022
  • Mastectomy and Immediate Breast Reconstruction with Pre-Pectoral or Sub-Pectoral Implant: Assessing Clinical Practice, Post-Surgical Outcomes, Patient’s Satisfaction and Cost 2 October, 2022
  • Prophylactic onlay mesh at emergency laparotomy: promising early outcomes with long-acting synthetic resorbable mesh 1 August, 2022
  • A Retrospective Study Assessing the Outcomes of Immediate Prepectoral and Subpectoral Implant and Mesh-Based Breast Reconstruction 29 June, 2022
  • Press Release CE MDR TIGR Matrix 12 January, 2022
Copyright 2023 © Novus Scientific • Virdings Allé 2, 754 50 Uppsala, SWEDEN • TIGR® Matrix Surgical Mesh received 510(k) clearance by the FDA in 2010 and carries the CE-mark since 2011.